Colestipol Hydrochloride

CHEMBL1201474 Phase 4 承認済み Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
225.8 g/mol
LogP
Phase
4

The hydrochloride salt of colestipol, a cholesterol-lowering resin that works by binding bile acids in the gut. It reduces LDL cholesterol and is also sometimes used to treat diarrhea caused by bile acid malabsorption.

分子量

225.7600 g/mol

TPSA

88.10 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(CNCCNCCNCCN)N.Cl

InChI

InChI=1S/C8H23N5.ClH/c9-1-3-11-5-7-13-8-6-12-4-2-10;/h11-13H,1-10H2;1H

Molecular Formula

C8H24ClN5

HBD / HBA

6 / 5

回転可能結合数

10

重原子数

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The hydrochloride salt of colestipol, a cholesterol-lowering resin that works by binding bile acids in the gut. It reduces LDL cholesterol and is also sometimes used to treat diarrhea caused by bile acid malabsorption.

Yes, Colestipol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201474. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3084661. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.